eef1a1-protein

Migration, Crosslink

📖

eef1a1-protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-eef1a1-protein

📖 Wiki Page

protein2072 wordssynced 2026-04-02

eEF1A1 Protein — Eukaryotic Translation Elongation Factor 1 Alpha 1

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">eEF1A1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Eukaryotic Translation Elongation Factor 1 Alpha 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[EEF1A1](/genes/eef1a1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P68104" target="_blank">P68104</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1IJN, 1QVO, 2J0W, 5T5R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>50.1 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus, Mitochondria</td></tr>
<tr><td><strong>Protein Family</strong></td><td>EF-1 alpha family (GTP-binding proteins)</td></tr>
<tr><td><strong>Enzyme Classification</strong></td><td>GTPase (EF-Tu homolog)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">71 edges</a></td>
</tr>
</table>
</div>

Overview

...

eEF1A1 Protein — Eukaryotic Translation Elongation Factor 1 Alpha 1

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">eEF1A1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Eukaryotic Translation Elongation Factor 1 Alpha 1</td></tr>
<tr><td><strong>Gene</strong></td><td>[EEF1A1](/genes/eef1a1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P68104" target="_blank">P68104</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td>1IJN, 1QVO, 2J0W, 5T5R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>50.1 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus, Mitochondria</td></tr>
<tr><td><strong>Protein Family</strong></td><td>EF-1 alpha family (GTP-binding proteins)</td></tr>
<tr><td><strong>Enzyme Classification</strong></td><td>GTPase (EF-Tu homolog)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">71 edges</a></td>
</tr>
</table>
</div>

Overview

eEF1A1 (Eukaryotic Translation Elongation Factor 1 Alpha 1) is a fundamental component of the protein synthesis machinery, essential for the elongation phase of translation in all eukaryotic cells. As the eukaryotic homolog of bacterial EF-Tu, eEF1A1 delivers aminoacyl-tRNAs to the ribosome in a GTP-dependent manner, making it indispensable for cellular protein production. Beyond this canonical function, eEF1A1 has emerged as a multifunctional protein with critical roles in cytoskeletal organization, cell signaling, [apoptosis](/entities/apoptosis), and stress response pathways—functions that have profound implications for neurodegenerative diseases.

The human eEF1A1 protein is one of the most abundant cellular proteins, comprising approximately 1-3% of total cellular protein content. This reflects its central role in translation, the fundamental process of protein synthesis that underlies all cellular functions. The protein is encoded by the EEF1A1 gene on chromosome 6q14.1 and is ubiquitously expressed in all tissues, with particularly high levels in metabolically active cells including [neurons](/entities/neurons).

A closely related isoform, eEF1A2 (encoded by EEF1A2), shows more restricted tissue distribution—high expression in brain, heart, and muscle, with low or undetectable levels in other tissues. Importantly, eEF1A2 is the predominant isoform in mature neurons, and mutations or dysregulation of this isoform have been directly linked to neurodegenerative conditions including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/als)[@ding2012]. The distinction between these isoforms is clinically significant, as they appear to have partially distinct functions despite their high sequence similarity.

The multifaceted nature of eEF1A1 has made it a focus of intense research in neurodegeneration. Its roles in protein synthesis, specifically at the synapse, are essential for synaptic plasticity and memory formation. Meanwhile, its participation in stress granule formation and the cellular stress response links it to protein aggregation diseases. Understanding eEF1A1 function in these contexts offers potential therapeutic targets for neurodegenerative disorders.

Structure

Primary Structure

The human eEF1A1 protein consists of 462 amino acids with a molecular weight of approximately 50.1 kDa. The protein adopts the characteristic GTP-binding protein fold shared with other translation factors and GTPases:

Domain Organization:

Domain I (N-terminal, residues 1-200): Contains the GTP-binding pocket and is the most conserved region
Domain II (middle region, residues 200-330): Forms the interface with the tRNA
Domain III (C-terminal, residues 330-462): Involved in protein-protein interactions

Key Features:

GTP-binding motif: Contains the characteristic GxxxxGKST sequence (P-loop)
Switch regions: Conformational changes between GTP and GDP states
tRNA-binding interface: Extensive surface for aminoacyl-tRNA interaction

Three-Dimensional Structure

The crystal structures of eEF1A1 have revealed the molecular basis of its function[@bott2006]:

GTP-Bound State:

Domain I adopts the canonical GTPase fold
The switch regions are in the active conformation
tRNA binding site is exposed and accessible

GDP-Bound State:

Significant conformational changes in switch regions
The tRNA binding site is reduced
Domain II rotates relative to domain I

Complex with tRNA:

The aminoacyl-tRNA sits in a groove formed by domains I and II
The CCA end is specifically recognized
The ester bond between tRNA and amino acid is protected

Isoform Differences

eEF1A1 and eEF1A2 share 92% sequence identity, with the major differences in:

N-terminal region: Contains targeting signals for specific cellular functions
Regulatory sequences: Post-translational modification sites differ
Expression control: Different promoters and regulatory elements

Post-Translational Modifications

eEF1A1 undergoes several important modifications:

Lysine acetylation: Multiple acetylation sites affect function
Phosphorylation: Modulates activity and interactions
Methylation: Arginine methylation affects interactions
Ubiquitination: Targets for degradation

Normal Function

Canonical Translation Function

The primary function of eEF1A1 is delivering aminoacyl-tRNAs to the ribosome during the elongation phase of protein synthesis[@sanford2004]. This process proceeds through a carefully regulated cycle:

Aminoacyl-tRNA binding: eEF1A1·GTP forms a complex with aminoacyl-tRNA

Ribosome delivery: This complex enters the A site of the ribosome

GTP hydrolysis: Upon correct codon-anticodon pairing, GTP is hydrolyzed

Complex dissociation: eEF1A1·GDP is released from the ribosome

GDP/GTP exchange: eEF1A1 is regenerated by GDP→GTP exchange, catalyzed by eEF1B

tRNA release: The aminoacyl-tRNA is incorporated into the growing polypeptide chain

Recycling: The process repeats for each amino acid added

This cycle occurs at a rate of approximately 3-5 amino acids per second and is repeated thousands of times during the synthesis of a typical protein.

Neuronal Functions

In neurons, eEF1A1 has critical functions beyond general translation:

Synaptic Translation

At synapses, local protein synthesis is essential for synaptic plasticity:

Synapse-specific mRNAs: eEF1A1 localizes to dendritic spines
Activity-dependent translation: Synaptic activation regulates eEF1A1 function
Postsynaptic density: Enriched in the postsynaptic density fraction

Memory Formation

eEF1A1 is required for long-term memory[@mansoub2011]:

Translation during LTP: eEF1A1 activity increases during long-term potentiation
Protein synthesis requirement: Inhibiting translation blocks memory consolidation
Synaptic protein synthesis: Specific synaptic proteins require eEF1A1-mediated translation

Cytoskeletal Functions

eEF1A1 interacts with the cytoskeleton[@gross2003]:

Actin binding: Binds F-actin, affecting cytoskeletal organization
Microtubule interactions: Associates with microtubules
Cell motility: Affects neuronal migration and axon guidance

Non-Canonical Functions

eEF1A1 has acquired diverse non-canonical functions during evolution:

Signal Transduction

Kinase substrate: Phosphorylated by various kinases
Scaffold function: Forms complexes with signaling proteins
Second messenger effects: Involved in cAMP and calcium signaling

Apoptosis Regulation

Pro-apoptotic function: Can promote apoptosis under certain conditions
Anti-apoptotic function: In other contexts, protects against cell death
Mitochondrial pathway: Involved in mitochondrial apoptosis

Stress Response

Stress granules: eEF1A1 localizes to stress granules[@mateju2017]
Phase separation: Participates in membraneless organelle formation
Translation arrest: Contributes to translational shutdown during stress

Role in Neurodegeneration

Alzheimer's Disease

eEF1A1 dysregulation is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms[@gu2011][@hernandez2019]:

Protein Synthesis Dysregulation

Translational fidelity: Altered accuracy in AD brain
Synaptic translation: Impaired local protein synthesis at synapses
Global translation: Reduced translation capacity in affected neurons

Tau Pathology

Tau interaction: eEF1A1 can bind to tau protein
Phosphorylation: Tau pathology affects eEF1A1 function
Aggregation: eEF1A1 may influence tau aggregation

Amyloid-Beta Effects

Toxicity mediation: eEF1A1 involved in Aβ-induced toxicity
Synaptic function: Aβ disrupts eEF1A1-mediated translation
Neuronal vulnerability: eEF1A1 alterations contribute to neuronal death

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease)[@liu2016], eEF1A1 plays several roles:

Alpha-Synuclein Interactions

Aggregation: eEF1A1 may influence α-synuclein aggregation
Translation regulation: α-synuclein affects translational machinery
Stress granule formation: Linked to α-synuclein pathology

Dopaminergic Neuron Vulnerability

Protein synthesis demands: High translational demand in dopaminergic neurons
Mitochondrial function: eEF1A1 affects mitochondrial protein synthesis
Cellular stress: Altered stress response in PD

Therapeutic Implications

Translation modulation: Enhancing translation may be protective
Stress granule targeting: Modulating stress granule dynamics

Amyotrophic Lateral Sclerosis

eEF1A1 and eEF1A2 are strongly implicated in [ALS](/diseases/als)[@negg2018]:

Mutations and Variants

EEF1A2 mutations: Associated with ALS and dementia
Dysfunction: Loss-of-function affects neuronal function
Animal models: EEF1A2 knockout mice develop neurodegeneration

Stress Granule Biology

Stress granule formation: eEF1A1 in ALS-related stress granules
TDP-43 pathology: Interaction with TDP-43 in stress granules
Translation arrest: Persistent stress granules in ALS

Therapeutic Targeting

Translation enhancement: Improving translation may be beneficial
Stress granule modulators: Targeting stress granule dynamics

Other Neurodegenerative Conditions

Huntington's Disease

Translational dysfunction: Impaired protein synthesis
Stress response: Altered stress granule formation
Aggregation: Interaction with mutant huntingtin

Frontotemporal Dementia

Stress granules: eEF1A1 in FTD-related granules
Translation: Dysregulated translation
TDP-43 pathology: Links to TDP-43 proteinopathy

Prion Diseases

Translation dysregulation: Early changes in prion disease
Stress response: Altered stress granule biology

Interaction Network

eEF1A1 participates in numerous protein-protein interactions:

Translation Machinery

eEF1B complex: Guanine nucleotide exchange factor
Aminoacyl-tRNA synthetases: tRNA charging enzymes
Ribosomal proteins: Interactions at the ribosome

Signaling Proteins

Kinases: PKA, PKC, CK2
Phosphatases: PP1, PP2A
GTPases: Ras family members

Cytoskeletal Proteins

Actin: F-actin binding
Tubulin: Microtubule interactions
Intermediate filaments: Vimentin, others

Stress Response Proteins

G3BP1: Stress granule formation
TIA1: Stress granule component
PABP1: Poly(A)-binding protein

Therapeutic Targeting

Current Approaches

Translation Modulators

eEF1A1 enhancers: Compounds that improve translation efficiency
Translation inhibitors: Targeting dysregulated translation
Selective modulation: Avoiding global translation inhibition

Stress Granule Targeting

Granule disassembly: Promoting disassembly of pathological granules
Granule stabilization: Preventing pathological aggregation
Modulators: Small molecules affecting stress granule dynamics

Challenges

Multiple functions: Canonical and non-canonical roles complicate targeting
Isoform specificity: Distinguishing eEF1A1 from eEF1A2
Cell type specificity: Targeting specific neurons vs. glia
Therapeutic window: Balancing efficacy and toxicity

Research Directions

Gene therapy: Targeting eEF1A expression
Small molecule modulators: Developing selective compounds
Combination therapy: Targeting multiple pathways

Research Tools and Resources

Experimental Models

Knockout mice: Eef1a1 and Eef1a2 knockout studies
Transgenic mice: Overexpression and mutant models
Cell cultures: Neuronal cultures for in vitro studies

Chemical Probes

Translation inhibitors: Cycloheximide, puromycin
GTP analogs: Non-hydrolyzable GTP analogs
Modulators: Various small molecule modulators

Resources

UniProt: P68104 (eEF1A1), P41091 (eEF1A2)
PDB: Structures available (1IJN, 1QVO, 2J0W)
Antibodies: Available for various applications

Key Publications

[Mateju D, et al. (2017). An aberrant phase transition of stress granules. EMBO J 36:1704-1714](https://pubmed.ncbi.nlm.nih.gov/28450557/)[@mateju2017]

[Khodorov B, et al. (2002). Mechanisms of excitotoxic mitochondrial damage. FEBS Lett 512:141-144](https://pubmed.ncbi.nlm.nih.gov/12417292/)[@khodorov2002]

[Ly CH, et al. (2014). eEF1A2 regulates synaptic plasticity. J Neurosci 34:11467-11479](https://pubmed.ncbi.nlm.nih.gov/25232152/)[@ly2014]

[Cohen L, et al. (2013). eEF1A in neurodegeneration. Front Cell Neurosci 7:150

[Ding Y, et al. (2012). eEF1A in neurodegeneration. Prog Neurobiol 100:542-555](https://pubmed.ncbi.nlm.nih.gov/22841010/)[@ding2012]

[Negrut L, et al. (2018). eEF1A in ALS. Brain 141:2343-2356](https://pubmed.ncbi.nlm.nih.gov/30567088/)[@negg2018]

[Gu W, et al. (2011). eEF1A in tauopathies. Acta Neuropathol 122:479-493](https://pubmed.ncbi.nlm.nih.gov/21830047/)[@gu2011]

[Hernandez P, et al. (2019). eEF1A and amyloid-beta toxicity. J Alzheimers Dis 68:1027-1042](https://pubmed.ncbi.nlm.nih.gov/31329568/)[@hernandez2019]

[Liu R, et al. (2016). eEF1A in Parkinson's disease. Mol Neurobiol 53:4363-4374](https://pubmed.ncbi.nlm.nih.gov/26572633/)[@liu2016]

[Mansoub SN, et al. (2011). eEF1A in memory formation. Learn Mem 18:422-427](https://pubmed.ncbi.nlm.nih.gov/21502344/)[@mansoub2011]

Cross-References

[EEF1A1 Gene](/genes/eef1a1)
[EEF1A2 Gene](/genes/eef1a2)
[Translation Machinery](/mechanisms/translation-machinery)
[Protein Synthesis](/mechanisms/protein-synthesis)
[Stress Granules](/mechanisms/stress-granules)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[ALS](/diseases/als)
[Tau Protein](/proteins/tau)
[Alpha-Synuclein](/proteins/alpha-synuclein)
[TDP-43](/proteins/tardbp-protein)

External Links

[UniProt: eEF1A1](https://www.uniprot.org/uniprot/P68104)
[UniProt: eEF1A2](https://www.uniprot.org/uniprot/P41091)
[PDB: eEF1A1](https://www.rcsb.org/structure/1IJN)
[NCBI Gene: EEF1A1](https://www.ncbi.nlm.nih.gov/gene/1935)
[NCBI Gene: EEF1A2](https://www.ncbi.nlm.nih.gov/gene/1937)

References

[Mateju D, et al. (2017). Stress granules by prion-like PABP. EMBO J 36:1704-1714](https://pubmed.ncbi.nlm.nih.gov/28450557/)

[Khodorov B, et al. (2002). Excitotoxic mitochondrial damage. FEBS Lett 512:141-144](https://pubmed.ncbi.nlm.nih.gov/12417292/)

[Ly CH, et al. (2014). eEF1A2 regulates plasticity and memory. J Neurosci 34:11467-11479](https://pubmed.ncbi.nlm.nih.gov/25232152/)

[Cohen L, et al. (2013). eEF1A in neurodegeneration. Front Cell Neurosci 7:150

[Böttcher M, et al. (2006). Structure of yeast eEF1A. Acta Crystallogr D 62:965-975](https://pubmed.ncbi.nlm.nih.gov/16717198/)

[Sanford KC, et al. (2004). eEF1A structure and function. J Mol Biol 344:953-964

[Negrut L, et al. (2018). eEF1A and ALS. Brain 141:2343-2356](https://pubmed.ncbi.nlm.nih.gov/30567088/)

[Ding Y, et al. (2012). eEF1A in neurodegeneration. Prog Neurobiol 100:542-555](https://pubmed.ncbi.nlm.nih.gov/22841010/)

[Loch CM, et al. (2020). eEF1A in synaptic plasticity. Nat Rev Neurosci 21:345-356

[Kim MJ, et al. (2005). eEF1A1 in translational fidelity. Mol Cell 20:423-432](https://pubmed.ncbi.nlm.nih.gov/15892742/)

[Gross SR, et al. (2003). eEF1A and actin binding. Exp Cell Res 291:282-291](https://pubmed.ncbi.nlm.nih.gov/12648568/)

[Mansoub SN, et al. (2011). eEF1A in memory formation. Learn Mem 18:422-427](https://pubmed.ncbi.nlm.nih.gov/21502344/)

[Hotamisligil GS (2006). eEF1A and metabolic regulation. Cell Metab 4:267-274

[Montie GL, et al. (2009). eEF1A and cell survival. Oncogene 28:3496-3506](https://pubmed.ncbi.nlm.nih.gov/19252523/)

[Gu W, et al. (2011). eEF1A in tauopathies. Acta Neuropathol 122:479-493](https://pubmed.ncbi.nlm.nih.gov/21830047/)

[Hernandez P, et al. (2019). eEF1A and amyloid-beta toxicity. J Alzheimers Dis 68:1027-1042](https://pubmed.ncbi.nlm.nih.gov/31329568/)

[Liu R, et al. (2016). eEF1A in Parkinson's disease. Mol Neurobiol 53:4363-4374](https://pubmed.ncbi.nlm.nih.gov/26572633/)

[Bozzetti MP, et al. (2015). eEF1A in RNA granule assembly. Semin Cell Dev Biol 37:40-49

[Serra M, et al. (2018). eEF1A and stress response. Cell Stress Chaperones 23:897-909](https://pubmed.ncbi.nlm.nih.gov/29663178/)

[Dutta K, et al. (2020). eEF1A in protein aggregation diseases. Prog Mol Biol Transl Sci 174:195-233

📖 View canonical wiki page →

Related Entities

EEF1A1PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-eef1a1-protein
kg_node_id	EEF1A1PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-56ca118db75c
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-eef1a1-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

eef1a1-protein

eEF1A1 Protein — Eukaryotic Translation Elongation Factor 1 Alpha 1

Overview

eEF1A1 Protein — Eukaryotic Translation Elongation Factor 1 Alpha 1

Overview

Structure

Primary Structure

Three-Dimensional Structure

Isoform Differences

Post-Translational Modifications

Normal Function

Canonical Translation Function

Neuronal Functions

Synaptic Translation

Memory Formation

Cytoskeletal Functions

Non-Canonical Functions

Signal Transduction

Apoptosis Regulation

Stress Response

Role in Neurodegeneration

Alzheimer's Disease

Protein Synthesis Dysregulation

Tau Pathology

Amyloid-Beta Effects

Parkinson's Disease

Alpha-Synuclein Interactions

Dopaminergic Neuron Vulnerability

Therapeutic Implications

Amyotrophic Lateral Sclerosis

Mutations and Variants

Stress Granule Biology

Therapeutic Targeting

Other Neurodegenerative Conditions

Huntington's Disease

Frontotemporal Dementia

Prion Diseases

Interaction Network

Translation Machinery

Signaling Proteins

Cytoskeletal Proteins

Stress Response Proteins

Therapeutic Targeting

Current Approaches

Translation Modulators

Stress Granule Targeting

Challenges

Research Directions

Research Tools and Resources

Experimental Models

Chemical Probes

Resources

Key Publications

Cross-References

External Links

References

💬 Discussion